[{"Assets_0_Q1_USD":2370647000.0,"CommonStockSharesOutstanding_0_Q1_shares":48124731.0,"EarningsPerShareBasic_1_Q1_USD":0.23,"EarningsPerShareDiluted_1_Q1_USD":0.23,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":33207000.0,"NetIncomeLoss_1_Q1_USD":11271000.0,"StockholdersEquity_0_Q1_USD":1734928000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":48178000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":48067000.0,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170503"}]